News

Recent technological advancements have made recovery from paralysis a real possibility for the first time in history.
Inhibition of LKKR2 may rescue neurons that are dying due to a type of Parkinson’s disease that is caused by a single genetic ...
The study suggests that targeted brain stimulation could help bridge this gap. Academic learning has profound implications ...
Experimental myosin inhibitor MT-125 sensitizes glioblastoma to radiation and kinase inhibitors, prolonging survival in mouse models.
Traditional and new laboratory tools along with advances in AI are outlining a new paradigm in human disease modeling.
Researchers have uncovered new patterns of DNA damage associated with specific chemotherapy drugs to guide cancer treatment for less effects.